Systemic sclerosis medications and risk of scleroderma renal crisis

Systemic sclerosis medications and risk of scleroderma renal crisis

Abstract Background Scleroderma Renal Crisis (SRC) is associated with significant morbidity and mortality. While prednisone is strongly associated with SRC, there are no previous large cohort studies that have evaluated ace inhibitor (ACEi) calcium channel blocker (CCB), angiotensin receptor blocker...

Full description

Bibliographic Details
Main Authors: S. M. Gordon, J. B. Hughes, R. Nee, R. S. Stitt, W. T. Bailey, D. J. Little, J. D. Edison, S. W. Olson
Format: Article
Language:English
Published: BMC 2019-07-01
Series:BMC Nephrology
Subjects:
Systemic sclerosis
Scleroderma renal crisis
Risk factors
ACE inhibitor, proteinuria
Online Access:http://link.springer.com/article/10.1186/s12882-019-1467-y

Internet

http://link.springer.com/article/10.1186/s12882-019-1467-y

Similar Items